StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)

Close on Nov 17, 2026Market cap $28.79MP/E –Yield –

Xtant Medical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Xtant Medical's revenue for the twelve months ending Jun 30, 2026 was $109.53M, down 14.3% year over year. For fiscal 2025 it was $133.93M, up 14.2% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $133.93M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$133.93M+14.2%
FY2024Dec 31, 2024$117.27M+28.4%
FY2023Dec 31, 2023$91.30M+57.5%
FY2022Dec 31, 2022$57.97M+4.9%
FY2021Dec 31, 2021$55.26M+3.6%
FY2020Dec 31, 2020$53.34M-17.5%
FY2019Dec 31, 2019$64.68M-10.4%
FY2018Dec 31, 2018$72.20M-12.6%
FY2017Dec 31, 2017$82.61M-8.2%
FY2016Dec 31, 2016$90.00M+51.7%
FY2015Dec 31, 2015$59.35M+68.0%
FY2014Dec 31, 2014$35.33M+6.8%
FY2013Dec 31, 2013$33.07M+0.3%
FY2012Dec 31, 2012$32.98M+9.4%
FY2011Dec 31, 2011$30.15M+95.6%
FY2010Dec 31, 2010$15.42M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.03M-35.0%
Q1 FY2026Mar 31, 2026$20.88M-36.5%
Q4 FY2025Dec 31, 2025$32.36M+2.7%
Q3 FY2025Sep 30, 2025$33.26M+19.0%
Q2 FY2025Jun 30, 2025$35.41M+18.3%
Q1 FY2025Mar 31, 2025$32.90M+18.0%
Q4 FY2024Dec 31, 2024$31.51M+12.1%
Q3 FY2024Sep 30, 2024$27.94M+11.7%
Q2 FY2024Jun 30, 2024$29.94M+48.0%
Q1 FY2024Mar 31, 2024$27.87M+55.3%
Q4 FY2023Dec 31, 2023$28.11M+84.1%
Q3 FY2023Sep 30, 2023$25.02M+73.0%
Q2 FY2023Jun 30, 2023$20.23M+32.4%
Q1 FY2023Mar 31, 2023$17.94M+38.5%
Q4 FY2022Dec 31, 2022$15.27M+9.3%
Q3 FY2022Sep 30, 2022$14.46M+5.0%
Q2 FY2022Jun 30, 2022$15.28M+2.0%
Q1 FY2022Mar 31, 2022$12.96M+3.3%
Q4 FY2021Dec 31, 2021$13.97M-0.3%
Q3 FY2021Sep 30, 2021$13.78M-1.7%
Q2 FY2021Jun 30, 2021$14.98M+42.2%
Q1 FY2021Mar 31, 2021$12.54M-15.1%
Q4 FY2020Dec 31, 2020$14.02M-17.4%
Q3 FY2020Sep 30, 2020$14.02M-10.8%
Q2 FY2020Jun 30, 2020$10.53M-31.1%
Q1 FY2020Mar 31, 2020$14.78M-11.6%
Q4 FY2019Dec 31, 2019$16.96M-7.1%
Q3 FY2019Sep 30, 2019$15.72M-8.9%
Q2 FY2019Jun 30, 2019$15.27M-18.5%
Q1 FY2019Mar 31, 2019$16.73M-6.7%
Q4 FY2018Dec 31, 2018$18.26M-5.5%
Q3 FY2018Sep 30, 2018$17.27M-12.7%
Q2 FY2018Jun 30, 2018$18.74M-12.5%
Q1 FY2018Mar 31, 2018$17.93M-18.8%
Q4 FY2017Dec 31, 2017$19.33M-21.0%
Q3 FY2017Sep 30, 2017$19.79M-14.3%
Q2 FY2017Jun 30, 2017$21.41M–
Q1 FY2017Mar 31, 2017$22.08M–
Q4 FY2016Dec 31, 2016$24.47M–
Q3 FY2016Sep 30, 2016$23.09M–

More Xtant Medical figures

See a number that looks wrong?